These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Glycyrrhizic acid and its hydrolysate as mineralocorticoid agonist. Takeda R; Miyamori I; Soma R; Matsubara T; Ikeda M J Steroid Biochem; 1987; 27(4-6):845-9. PubMed ID: 2826910 [TBL] [Abstract][Full Text] [Related]
25. A novel effect of molybdate on the binding of [3H]aldosterone to gel-filtered type I receptors in brain cytosol. Emadian SM; Luttge WG Neurochem Res; 1988 Aug; 13(8):707-13. PubMed ID: 2971889 [TBL] [Abstract][Full Text] [Related]
26. Corticosteroid-binding studies in cytosol of colonic mucosa of the rat. Marusic ET; Hayslett JP; Binder HJ Am J Physiol; 1981 Jun; 240(6):G417-23. PubMed ID: 7246742 [TBL] [Abstract][Full Text] [Related]
28. Comparison of corticosteroid binder IB with the alpha-chymotrypsin- and RNase-treated hepatic glucocorticoid receptors. Mayer M; Schmidt TJ; Miller A; Litwack G J Steroid Biochem; 1983 Dec; 19(6):1719-28. PubMed ID: 6672455 [TBL] [Abstract][Full Text] [Related]
29. Analysis of renal and hippocampal type I and type II receptors by fast protein liquid chromatography. Doyle D; Krozowski Z; Morgan FJ; Funder JW J Steroid Biochem; 1988 Apr; 29(4):415-21. PubMed ID: 2836656 [TBL] [Abstract][Full Text] [Related]
30. Changes in glucocorticoid and mineralocorticoid receptors of liver and kidney cytosols after pathologic stress and its regulation in rats. Liu DH; Su YP; Zhang W; Lu SF; Ran XZ; Gao JS; Cheng TM Crit Care Med; 2002 Mar; 30(3):623-7. PubMed ID: 11990926 [TBL] [Abstract][Full Text] [Related]
31. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system. Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276 [TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid and mineralocorticoid receptors in rat neocortical and hippocampal brain cells in culture: characterization and regulatory studies. Vedder H; Weiss I; Holsboer F; Reul JM Brain Res; 1993 Mar; 605(1):18-24. PubMed ID: 8467386 [TBL] [Abstract][Full Text] [Related]
33. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone. Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101 [TBL] [Abstract][Full Text] [Related]
34. Evidence of high affinity, stereoselective binding sites for [3H]-aldosterone in the spinal cord. Orti E; Magariños AM; De Nicola AF Neuroendocrinology; 1986; 43(3):404-9. PubMed ID: 2942793 [TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of glucocorticoid receptors of rat testis. Kalimi M; Shen J; Hubbard J J Steroid Biochem; 1983 Sep; 19(3):1265-72. PubMed ID: 6621035 [TBL] [Abstract][Full Text] [Related]
36. Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates. Luzzani F; Glässer A Biochem Pharmacol; 1984 Jul; 33(14):2277-81. PubMed ID: 6235813 [TBL] [Abstract][Full Text] [Related]
37. Affinity of corticosteroids for mineralocorticoid and glucocorticoid receptors of the rabbit kidney: effect of steroid substitution. Rafestin-Oblin ME; Lombes M; Lustenberger P; Blanchardie P; Michaud A; Cornu G; Claire M J Steroid Biochem; 1986 Oct; 25(4):527-34. PubMed ID: 3022076 [TBL] [Abstract][Full Text] [Related]